National Bank of Canada
IMGN

National Bank of Canada’s Immunogen Inc IMGN Stock Holding History

National Bank of Canada’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,000
Closed -$37.7K – 2914
2023
Q2 		$37.7K Hold
2,000
– – ﹤0.01% 1849
2023
Q1 		$7.68K Hold
2,000
– – ﹤0.01% 2208
2022
Q4 		$9.9K Hold
2,000
– – ﹤0.01% 2180
2022
Q3 		$10K Hold
2,000
– – ﹤0.01% 2192
2022
Q2 		$9K Hold
2,000
– – ﹤0.01% 2313
2022
Q1 		$10K Hold
2,000
– – ﹤0.01% 2403
2021
Q4 		$15K Buy
+2,000
New +$12.4K ﹤0.01% 2238

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

National Bank of Canada's IMGN Position: Q3 2023 in Review

National Bank of Canada sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 2,000 shares — an estimated $37.7K sold.

National Bank of Canada first reported a position in IMGN in Q4 2021 and held it in 7 quarters. The position peaked at $37.7K in Q2 2023. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

  • National Bank of Canada reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
  • National Bank of Canada sold 2,000 Immunogen Inc shares in Q3 2023, an estimated $37.7K.
  • National Bank of Canada first reported a position in Immunogen Inc in Q4 2021 and held it in 7 quarters.
  • National Bank of Canada's Immunogen Inc position peaked at $37.7K in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on National Bank of Canada's 13F filing for Q3 2023, filed 10 Oct 2023.